Events

Anglo Nordic Life Sciences Day

Date/Time
Date(s) - 04 May 17
All Day

Location
8 Northumberland Avenue
8 Northumberland Avenue
London


United Kingdom

Organizers
Anglo Nordic

Loading Map....

The Anglonordic Life Science Conference

The Anglonordic Life Science Conference XIV will be held in London on the 4th of May 2017. Now entering its fourteenth year the conference has successfully moved into a new prestigious venue just a few steps from Trafalgar Square. The new venue, 8 Northumberland Avenue, is London’s most central venue.

The conference continues to grow and gives you the opportunity to meet decision makers representing leading and upcoming drug discovery and medtech companies from the Anglo-Nordic regions, international pharmaceuticals and investment firms. The conference will continue with its successful concept and keep its ”by-invitation-only” policy. Service suppliers can only attend as sponsors or exhibitors.

At the conference 2016, 85 investors representing 70 investment firms attended.

The conference 2016 started with an exclusive Reception, held at Australia House. The guest of honour at the Reception was George Freeman, Minister for Life Sciences in the UK.

Visit the event website here

PCI Pharma Services will be attending this event on 4th May 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

3 + 3 =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...